Vertex Pharmaceuticals (VRTX) Net Equity Issued and Repurchased (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Net Equity Issued and Repurchased of $47.7 million for Q2 2026, down 2.9% from $49.1 million a year earlier but up 76.7% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Vertex Pharmaceuticals was $136.6 million, up 25.9% year-over-year; for FY2025, it was $127.7 million, up 11.4% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -13.6% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Net Equity Issued and Repurchased was $114.6 million in FY2024 (-14.9%), $134.6 million in FY2023 (-27.8%), $186.3 million in FY2022 (+82.6%) and $102 million in FY2021 (-61.5%).
- Quarterly Net Equity Issued and Repurchased has run from a low of $7.9 million in Q3 2025 to a high of $64.4 million in Q2 2022 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last eight quarters, with growth averaging 3.4%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2022, with growth of 165.2%; the weakest was Q3 2023, with a decline of 57.9%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $27 million (Q1 2026), $54 million (Q4 2025) and $7.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | -421.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -421.80 Mn |
| Mar 31, 2026 | -309.90 Mn |
| Dec 31, 2025 | -74.40 Mn |
| Sep 30, 2025 | -1.06 Bn |
| Jun 30, 2025 | -342.70 Mn |
| Mar 31, 2025 | -409.40 Mn |
| Dec 31, 2024 | -383.60 Mn |
| Sep 30, 2024 | -299.30 Mn |
| Jun 30, 2024 | -265.30 Mn |
| Mar 31, 2024 | -114.30 Mn |
| Dec 31, 2023 | -103.10 Mn |
| Sep 30, 2023 | -101.60 Mn |
| Jun 30, 2023 | 30.30 Mn |
| Mar 31, 2023 | -118.60 Mn |
| Dec 31, 2022 | 51.60 Mn |
| Sep 30, 2022 | 36.60 Mn |
| Jun 30, 2022 | 64.40 Mn |
| Mar 31, 2022 | 33.70 Mn |
| Dec 31, 2021 | -333.50 Mn |
| Sep 30, 2021 | -618.50 Mn |
API Access
Vertex Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();